Company Filing History:
1 out of 676 
1 out of 158 
Years Active: 2006
Title: Virginie Fataccioli: Innovator in Connective Tissue Research
Introduction
Virginie Fataccioli is a notable inventor based in Thiais, France. She has made significant contributions to the field of biotechnology, particularly in the area of connective tissue growth factors. Her work has implications for therapeutic applications in tissue repair and wound healing.
Latest Patents
Virginie Fataccioli holds a patent for a human CTGF-2 polypeptide and the DNA (RNA) encoding such polypeptide. This invention includes a procedure for producing the polypeptide through recombinant techniques. Additionally, it encompasses antibodies and antagonists/inhibitors against the polypeptide. The patent also outlines methods for using the polypeptide therapeutically to stimulate angiogenesis, enhance the repair of connective and support tissue, promote the attachment and stabilization of tissue implants, and improve wound healing. Furthermore, diagnostic assays for identifying mutations in the nucleic acid sequence encoding the polypeptide and for detecting altered levels of the polypeptide are disclosed.
Career Highlights
Throughout her career, Virginie has worked with prominent companies in the biotechnology sector, including Human Genome Sciences, Inc. and Transgene S.A. Her experience in these organizations has contributed to her expertise in the development of innovative therapeutic solutions.
Collaborations
Some of her notable coworkers include Haodong Li and Mark D. Adams. Their collaborative efforts have likely enhanced the research and development of her patented technologies.
Conclusion
Virginie Fataccioli's contributions to the field of connective tissue research exemplify her innovative spirit and dedication to advancing medical science. Her patent on CTGF-2 highlights the potential for significant therapeutic applications in tissue repair and healing.